Sheena Marie Bonebrake, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 8131 Spyglass Hill Dr, Fayetteville, PA 17222 Phone: 717-264-5211 Fax: 717-264-5418 |
News Archive
GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company researching a new class of glycobiology-based therapies for a broad range of diseases, today announced that it has completed enrolling patients in its Phase 2 study of GMI-1070, its lead investigational drug candidate.
"Kenyans marked the World Mental Health Day Monday with a pledge to increase public investments in the treatment of mental illnesses, which affects at least 10 million people in the East African nation," Afrique en ligne reports, adding, "Kenya's Medical Services Minister Anyang Nyong'o said estimates show that at least one in every four Kenyans suffer from one form of mental-health related ailment."
A large new American Cancer Society study adds to increasing evidence that physical activity reduces the risk of breast cancer in postmenopausal women. Researchers say moderate recreational activity was associated with a 14 percent lower risk and high physical activity with a 25 percent lower risk of breast cancer compared to women who were active at the lowest level.
Among patients with early-stage breast cancer that had spread to a nearby lymph node and who received treatment that included lumpectomy and radiation therapy, women who just had the sentinel lymph node removed did not have worse survival than women who had more extensive axillary lymph node dissection, according to a study in the February 9 issue of JAMA.
Concert Pharmaceuticals, Inc. today announced that three abstracts relating to CTP-499, its clinical candidate for the potential treatment of diabetic nephropathy, have been accepted for poster presentations at the American Society of Nephrology's (ASN) Kidney Week 2011.
› Verified 3 days ago